Journal of Andrology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kim, N. N.
Right arrow Articles by Goldstein, I.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kim, N. N.
Right arrow Articles by Goldstein, I.

Journal of Andrology, Vol 23, Issue 1 76-83, Copyright © 2002 by The American Society of Andrology


JOURNAL ARTICLE

Pilot study of the endothelin-A receptor selective antagonist BMS-193884 for the treatment of erectile dysfunction

N. N. Kim, V. Dhir, K. M. Azadzoi, A. M. Traish, E. Flaherty and I. Goldstein
Department of Urology, Boston University School of Medicine, Massachusetts 02118, USA. nnkim@bu.edu

Endothelins have been postulated to be important regulators of penile erectile function. The endothelin-A receptor antagonist BMS-193884 was evaluated as a treatment for mild-to-moderate erectile dysfunction in an animal model and in human volunteer subjects. In laboratory studies, organ bath preparations of rabbit and human penile cavernosal tissue strips were incubated with BMS-193884 and exposed to increasing concentrations of endothelins. In rabbit tissue, 1 microM BMS-193884 significantly inhibited contraction to ET-1, ET-2, and ET-3 by 34.5%, 42.9%, and 100%, respectively. In human tissue, 1 microM BMS-193884 inhibited contraction to ET-2 by 44.4%. In rabbit tissue strips contracted with 20 nM of ET-1 or ET-2, BMS-1 93884 caused dose-dependent relaxation with EC50 values of 107.2 +/- 32.3 nM and 1.7 +/- 0.5 nM, respectively. In anesthetized male rabbits, intravenous administration of BMS-193884 (systemic plasma concentration approximately 50 and 100 nM) increased the duration of pelvic nerve-stimulated penile erection. To further assess the safety and efficacy of BMS-193884, 53 men diagnosed with mild-to-moderate erectile dysfunction were administered oral placebo or 100 mg BMS-193884 in a double-blind fashion. Evaluations were based on 1) erectile function testing during 2 in-office visits and 2) diary and questionnaire data of 4 intercourse attempts over 2-4 weeks of home use. Although the drug was well tolerated, BMS-193884 did not significantly improve erectile function during office visits or home use when compared to placebo. Thus, BMS-193884 facilitated cavernosal smooth muscle relaxation ex vivo and prolonged penile tumescence in vivo. In contrast, a pilot clinical study failed to show enhancement of erectile response in men with mild-to-moderate erectile dysfunction. The disparity between the laboratory and clinical studies suggests that there may be differences between species with regard to the role of endothelin in erectile function.


This article has been cited by other articles:


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
M. Imamura, Y. Waseda, G. V. Marinova, T. Ishibashi, S. Obayashi, A. Sasaki, A. Nagai, and H. Azuma
Alterations of NOS, arginase, and DDAH protein expression in rabbit cavernous tissue after administration of cigarette smoke extract
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2007; 293(5): R2081 - R2089.
[Abstract] [Full Text] [PDF]


Home page
Exp. Biol. Med.Home page
B. Battistini, N. Berthiaume, N. F. Kelland, D. J. Webb, and D. E. Kohan
Profile of Past and Current Clinical Trials Involving Endothelin Receptor Antagonists: The Novel "-Sentan" Class of Drug.
Experimental Biology and Medicine, June 1, 2006; 231(6): 653 - 695.
[Abstract] [Full Text] [PDF]


Home page
J. Pharmacol. Exp. Ther.Home page
R. B. Moreland, J. D. Brioni, and J. P. Sullivan
Emerging Pharmacologic Approaches for the Treatment of Lower Urinary Tract Disorders
J. Pharmacol. Exp. Ther., March 1, 2004; 308(3): 797 - 804.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Filippi, M. Marini, G.B. Vannelli, C. Crescioli, S. Granchi, L. Vignozzi, M. Luconi, P. Ferruzzi, A. Morelli, G. Forti, et al.
Effects of hypoxia on endothelin-1 sensitivity in the corpus cavernosum
Mol. Hum. Reprod., December 1, 2003; 9(12): 765 - 774.
[Abstract] [Full Text] [PDF]


Home page
J AndrolHome page
T. J. Bivalacqua, M. F. Usta, H. C. Champion, P. J. Kadowitz, and W. J. G. Hellstrom
Endothelial Dysfunction in Erectile Dysfunction: Role of the Endothelium in Erectile Physiology and Disease
J Androl, November 1, 2003; 24(6_suppl): S17 - S37.
[Full Text] [PDF]


Home page
Am. J. Physiol. Regul. Integr. Comp. Physiol.Home page
C. J. Wingard, S. Husain, J. Williams, and S. James
RhoA-Rho kinase mediates synergistic ET-1 and phenylephrine contraction of rat corpus cavernosum
Am J Physiol Regulatory Integrative Comp Physiol, November 1, 2003; 285(5): R1145 - R1152.
[Abstract] [Full Text] [PDF]


Home page
Mol Hum ReprodHome page
S. Granchi, G.B. Vannelli, L. Vignozzi, C. Crescioli, P. Ferruzzi, R. Mancina, M.C. Vinci, G. Forti, S. Filippi, M. Luconi, et al.
Expression and regulation of endothelin-1 and its receptors in human penile smooth muscle cells
Mol. Hum. Reprod., December 1, 2002; 8(12): 1053 - 1064.
[Abstract] [Full Text] [PDF]


Home page
Vasc MedHome page
R. Maas, E. Schwedhelm, J. Albsmeier, and R. H Boger
The pathophysiology of erectile dysfunction related to endothelial dysfunction and mediators of vascular function
Vascular Medicine, August 1, 2002; 7(3): 213 - 225.
[Abstract] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2002 by The American Society of Andrology.